Selegiline hydrochloride

DRUG4 trials

Sponsors

The Dana Foundation, National Institute of Allergy and Infectious Diseases (NIAID), National Institute on Drug Abuse (NIDA)

Conditions

Cognition DisordersCognitive DisordersHIV InfectionsMarijuana Abuse

Phase 2

Safety and Effectiveness of the Selegiline Patch for Decreased Mental Function in HIV Patients

CompletedNCT00013585

National Institute of Allergy and Infectious Diseases (NIAID)Cognition Disorders, HIV Infections

End: 2005-12-31Updated: 2021-11-01

A Study of Thioctic Acid and Deprenyl in HIV-Infected Patients With Dementia

CompletedNCT00002154

The Dana FoundationCognitive Disorders, HIV Infections

Target: 32Updated: 2005-06-24

Effectiveness of Selegiline in Treating Marijuana Dependent Individuals - 1

CompletedNCT00218517

National Institute on Drug Abuse (NIDA)Marijuana Abuse

Start: 2005-03-31End: 2007-07-31Updated: 2017-01-12

Unknown Phase

A Study of Decreased Mental Function Associated With HIV

CompletedNCT00027040

National Institute of Allergy and Infectious Diseases (NIAID)Cognitive Disorders, HIV Infections

End: 2005-06-30Target: 90Updated: 2015-01-16